Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein Kinase A (PKA) RIα regulatory subunit controls PKA activity by binding to catalytic subunits and inhibiting them. Binding of cAMP to RIα releases the catalytic subunits, activating PKA. RIα also interacts with AKAPs to localize PKA to specific cellular compartments, enabling spatial-temporal control of signaling. Mutations in PRKAR1A are associated with Carney complex, a multiple neoplasia syndrome.
Inhibits catalytic subunit of PKA in the absence of cAMP; releases catalytic subunit upon cAMP binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Kinase A Regulatory Subunit Type I Alpha (RIα).